Meningitis Vaccine Study
Overview of Meningitis Vaccine Medical Research Study
Our current Meningitis Vaccine medical research study is a 12 month outpatient study, with 6 required in office clinic visits. This research study will help us learn about vaccines protecting against diseases caused by different types of meningococcus germs (types A, B, C, W, Y).
What is Meningitis?
Several different germs can cause a serious infection of the blood and nervous system. A germ (bacterium) called Meningococcus, also called Neisseria meningitidis, can cause several serious diseases, including meningitis and infection of the blood. Meningitis affects the brain and spinal cord.
It can cause hearing loss, seizures, learning and behavior problems, severe brain damage and even death (death is caused in about half the cases if left untreated). Meningitis can happen to anyone but is more common in teenagers, and young children (including babies). Vaccines work by helping your body make proteins called antibodies.
You may be eligible to take part in the study if you:
Are between the ages of 10 and 25 years old
Have never received a vaccine for meningitis B
Never received or have received only one dose of MenACWY vaccine at least
4 years ago (with the exception of meningococcal C vaccination if the last dose
of MenC was received at 24 months of age or earlier)
You may be compensated for time and travel, up to $100 for each completed study visit and $25 for your each phone call visit.
If you are interested in participating in this medical research study, feel free to contact us today to learn more about our current study opportunity. Signup online by completing the contact form below, or email our Clinical Care Coordinator, Shamera Jackson at email@example.com. You can also call us at 803.764.2406 or TEXT us at 803.291.4972.